1. Home
  2. STIM vs PLX Comparison

STIM vs PLX Comparison

Compare STIM & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.23

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.22

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
PLX
Founded
2003
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.6M
168.4M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
STIM
PLX
Price
$1.23
$2.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
1.6M
627.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.25
N/A
EPS
N/A
0.22
Revenue
$52,776,000.00
$52,744,000.00
Revenue This Year
$11.10
$36.81
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
$10.09
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$1.36
52 Week High
$4.84
$3.19

Technical Indicators

Market Signals
Indicator
STIM
PLX
Relative Strength Index (RSI) 42.89 62.90
Support Level $1.21 $2.03
Resistance Level $1.75 $2.42
Average True Range (ATR) 0.12 0.07
MACD -0.01 0.02
Stochastic Oscillator 7.27 98.21

Price Performance

Historical Comparison
STIM
PLX

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: